Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senior Reporter
UK
5+ years of experience
Vibha's fields of interest include the EU Pharmacovigilance legislation and the EU Pediatrics Regulation, on which she has written several exclusive articles from various industry conferences. She has also commissioned some pieces of expert analysis on major developments in the pharma and medtech regulatory arenas.
Before joining Informa, she was principal correspondent with India's national newspaper Hindustan Times, where she reported on health and medical issues, besides several other topics. She has also worked with two other Indian national dailies, The Indian Express and The Asian Age.
Pink Sheet
By Vibha Sharma 18 Jan 2022
The EU will make it mandatory for clinical trial sponsors to prepare layperson summaries of their study results. Industry practices around content presentation, translation and dissemination of these documents will be keenly watched.
Pink Sheet
By Vibha Sharma 22 Apr 2021
A simplified process for registering and evaluating clinical trials promised by the EU Clinical Trial Regulation is finally set to become a reality.
Scrip
By Vibha Sharma 29 Nov 2020
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
Topic Coronavirus Vaccines
Pink Sheet
By Vibha Sharma 27 Nov 2020
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
Topic EU Innovation Regulation
Pink Sheet
By Vibha Sharma 09 Sep 2020
The UK’s approach to pharmacovigilance system requirements in the post-Brexit transition period will allow companies to leverage some of the existing structures put in place for EU systems.
Topic Pharma-Brexit Brexit
Medtech Insight
By Vibha Sharma 22 Aug 2018
The Canadian government has made it mandatory for hospitals to report medical device incidents and serious adverse reactions in their control irrespective of where these incidents originate.
Topic Medtech
Pink Sheet
By Vibha Sharma 19 Jan 2018
The European Commission's plans to evaluate the EU pediatric and orphan drugs regulation in tandem.
Topic Rare Diseases
Pink Sheet
By Vibha Sharma 24 Mar 2017
A new draft guideline from the European Medicines Agency on pharmacovigilance requirements relating to medicines taken during pregnancy and breastfeeding has been delayed and will now be issued for stakeholder consultation by the end of 2017.
Topic BioPharmaceutical
Pink Sheet
26 Jul 2022
Pink Sheet
25 Jul 2022
Pink Sheet
22 Jul 2022
Pink Sheet
21 Jul 2022
Pink Sheet
20 Jul 2022
Pink Sheet
20 Jul 2022
Pink Sheet
19 Jul 2022
Pink Sheet
14 Jul 2022
Pink Sheet
12 Jul 2022
Pink Sheet
04 Jul 2022
Medtech Insight
04 Jul 2022
Pink Sheet
27 Jun 2022
Pink Sheet
22 Jun 2022
Pink Sheet
21 Jun 2022
Pink Sheet
20 Jun 2022
